Skip to content
AdminMar 25, 2020< 1 min read

Empirical Assessment of Privacy Risks in Data

2020-03-05-Empirical-Assessment-of-Privacy-Risks-in-Data

Khaled El Emam, SVP & GM, Replica Analytics; Janice Branson, Global Head of Advanced Methodology & Data Science, Novartis; Nathan Good, Principal, Good Research

Presentation on our experiences with trying to identify individuals in datasets that have been de-personalized, especially health data. This is an overview of Motivated Intruder Attacks.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

Natalie Schibell, MPHNov 21, 20243 min read

Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact

Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is relentless, but the key to unlocking ...
Start Reading
AdminNov 20, 2024< 1 min read

Frameworks and Tools for Generating Decision-Grade RWE | Jan 12, 2023

Watch the webinar Frameworks and Tools for Generating Decision-Grade RWE to explore essential tools and templates to better ...
Start Reading
AdminOct 31, 20243 min read

Applying AI to RWE and Drug Development

With applications abound, AI is poised to change how RWD/RWE teams operate and how quickly they can accelerate drug ...
Start Reading